ADAA members receive a complimentary annual online subscription to Depression and Anxiety. With an impact factor of 5.004, this journal ranks 19 of 140 in psychiatry journals and 10 of 76 in psychology journals.

Capture_0.JPG

Depression and Anxiety, the official online journal of the Anxiety and Depression Association of America welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans.

A priority is placed on papers focusing on treatment, as well as those providing cutting-edge reviews of key areas and issues, in order to enhance the clinical evaluation and care of individuals struggling with the effects of these disorders. All submissions are peer-reviewed; there is no handling or publishing fee.

NOTE: You must be a current member to log in. Download member log-in instructions here.

If you have questions about your login, please contact ADAA Membership.

Please note: Three open-access journals, the Journal of Depression & Anxiety (OMICS); Anxiety and Depression Research (Herbert Publications); and Annals of Depression and Anxiety (Austin Publishing) are not affiliated with ADAA. These publishers require payment of a handling or submissions fee from authors; find information about these fees on their websites. These publications are not related to Depression and Anxiety, the official ADAA journal.

We invite you to read and share the following early release articles from the February 2017 Journal:

ADAA President Letter

Karen Lynn Cassiday PhD, ACT

Theoretical Review

Defining Biotypes for Depression and Anxiety Based on Large-Scale Circuit Dysfunction: A Theoretical Review of the Evidence and Future Directions for Clinical Translation
Leanne M Williams PhD

Research Article

Persistent maternal depressive symptoms trajectories influence children's IQ: The EDEN mother–child cohort
Judith van der Waerden MSc, PhD, Jonathan Y. Bernard PhD, Maria De Agostini PhD,
Marie-Josèphe Saurel-Cubizolles PhD, Hugo Peyre MD, PhD, Barbara Heude PhD,
Maria Melchior ScD

Depression impacts the physiological responsiveness of mother–daughter dyads during social interaction
Marlissa C. Amole MS, Jill M. Cyranowski PhD, Aidan G. C. Wright PhD, Holly A. Swartz MD

Oxytocin response to youth–mother interactions in clinically anxious youth is associated with separation anxiety and dyadic behavior
Eli R. Lebowitz PhD, Wendy K. Silverman PhD, Alyssa M. Martino BA, Orna Zagoory-Sharon PhD, Ruth Feldman PhD, James F. Leckman MD, PhD

Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year
Aimee R. Kroll-Desrosiers MS, Benjamin C. Nephew PhD, Jessica A. Babb PhD, Yurima Guilarte-Walker M.S., Tiffany A. Moore Simas MD, MPH, MEd., Kristina M. Deligiannidis MD

Journal Articles in the News

A Common Medication Given to New Moms Has Been Linked to Postpartum Depression published in GoodHousekeeping (February 10, 2017). Covers "Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year" study by Aimee R. Kroll-Desrosiers MS, Benjamin C. Nephew PhD, Jessica A. Babb PhD, Yurima Guilarte-Walker MS, Tiffany A. Moore Simas MD, MPH, MEd, Kristina M. Deligiannidis MD.